Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07836010
PHASE4
Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy
Sponsor: Duke University
View on ClinicalTrials.gov
Summary
This study will assess the analgesic efficacy of suzetrigine as part of a multimodal analgesic regimen in women undergoing laparoscopic or robotic hysterectomy. Outcomes will be compared with matched historical controls receiving the current ERAS regimen without suzetrigine.
Official title: The Impact of Adding Suzetrigine to Multimodal Analgesia for Minimally Invasive Hysterectomy
Key Details
Gender
FEMALE
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
123
Start Date
2026-11
Completion Date
2028-02
Last Updated
2026-09-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Suzetrigine
Suzetrigine is an oral non-opioid pain medication used to treat moderate-to-severe acute pain in adults.